Metastatic Breast Cancer Pipeline Outlook, FDA Approvals, Clinical Trials and Companies 2024 (Updated)

working in the market include Roche, RemeGen, SynCore Biotechnology, Allarity Therapeutics, Daiichi Sankyo… * EndoTAG Registered -1 (SB05): SynCore Biotechnology